(S)-(+)-Ibuprofen
Names
[ CAS No. ]:
51146-56-6
[ Name ]:
(S)-(+)-Ibuprofen
[Synonym ]:
(2S)-2-(4-Isobutylphenyl)propanoic acid
(S)-(+)-4-Isobutyl-α-methylphenylacetic Acid
(S)-2-(4-Isobutylphenyl)propanoic acid
Benzeneacetic acid, α-methyl-4-(2-methylpropyl)-, (αS)-
(+)-(S)-Ibuprofen
(+)-ibuprofen
MFCD00069289
Dexibuprofen
(S)-4-Isobutyl-α-methylphenylacetic acid
(2S)-2-[4-(2-methylpropyl)phenyl]propanoic acid
(S)-(+)-Ibuprofen
(S)-(+)-2-(4-isobutylphenyl)propanoic acid
d-Ibuprofen
(S)-(+)-4-Isobutyl-Alpha-Methylphenylacetic Acid
Ibuprofen
(S)-(+)-2-(4-Isobutylphenyl)propionic Acid
(S)-a-Methyl-4-(2-methylpropyl)benzeneacetic acid
(S)-ibuprofen
(2S)-2-[4-(2-Methylpropyl)phenyl]propionic acid
Biological Activity
[Description]:
[Related Catalog]:
[Related Small Molecules]
Chemical & Physical Properties
[ Density]:
1.0±0.1 g/cm3
[ Boiling Point ]:
319.6±11.0 °C at 760 mmHg
[ Melting Point ]:
49-53ºC
[ Molecular Formula ]:
C13H18O2
[ Molecular Weight ]:
206.281
[ Flash Point ]:
216.7±14.4 °C
[ Exact Mass ]:
206.130676
[ PSA ]:
37.30000
[ LogP ]:
3.72
[ Vapour Pressure ]:
0.0±0.7 mmHg at 25°C
[ Index of Refraction ]:
1.519
MSDS
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ Hazard Codes ]:
Xn:Harmful;
[ Risk Phrases ]:
R22;R63
[ Safety Phrases ]:
S36/37-S45
[ RIDADR ]:
2811.0
[ WGK Germany ]:
3
[ Hazard Class ]:
6.1
[ HS Code ]:
2916399090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2916399090
[ Summary ]:
2916399090 other aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%
Articles
Nat. Chem. Biol. 3(5) , 268-273, (2007)
The identification of self-renewing and multipotent neural stem cells (NSCs) in the mammalian brain holds promise for the treatment of neurological diseases and has yielded new insight into brain canc...
The advantages and limitations of the analgesics available for control of postoperative pain after a dental procedure.SAAD Dig. 29 , 70-81, (2013)
Pegylation improves the pharmacokinetics and bioavailability of small-molecule drugs hydrolyzable by esterases: a study of phospho-Ibuprofen.
J. Pharmacol. Exp. Ther. 351(1) , 61-6, (2014)
Esterase hydrolysis of drugs can accelerate their elimination, thereby limiting their efficacy. Polyethylene glycol (PEG) covalently attached to drugs (pegylation) is known to improve the efficiency o...